Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is given as a once-weekly injection under the skin, using a pre-filled KwikPen. Treatment starts at the 2.5 mg dose and is increased gradually, in steps agreed with your prescriber, until you reach the dose that works best for you. Because it is a prescription-only medicine, a clinician must assess your suitability before you can take tirzepatide at all. The full process, from your first pen to ongoing dose changes, is described below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Each Mounjaro KwikPen holds four doses, so one pen lasts a month. Before you use it for the first time each week, take it out of the fridge and let it sit at room temperature for about 30 minutes — a cold injection is uncomfortable and there is no clinical benefit to injecting straight from the fridge. While you wait, wash your hands thoroughly.
Check the pen label against your prescription to confirm the strength, and inspect the liquid through the viewing window. It should be clear to slightly yellow and free from particles. If it looks cloudy or contains visible solids, do not use it; contact your prescribing team or pharmacy. Collect a fresh alcohol swab and have a sharps container nearby before you go any further. The NHS tirzepatide patient page has a plain-English overview of the preparation steps and what to check before each dose.
Storage matters too. The pen lives in the fridge between doses. For the exact room-temperature window (how long it may sit out safely before being discarded) always refer to the Patient Information Leaflet in the box, because that window is product-specific and should not be guessed at.
You can inject into three areas: the soft skin of your abdomen (at least a couple of centimetres from the navel), the front or outer thigh, or the upper arm. All three are equally effective; the main thing is to rotate the precise spot within whichever area you choose, week by week. Injecting repeatedly into the same small patch of skin can cause localised reactions, so a little variation protects the tissue.
Clean the chosen area with an alcohol swab and let it dry fully, about 10 seconds. Do not blow on it or fan it; just wait. For detailed guidance on injection technique and site rotation, including what to do if you notice a lump or bruise at a previous site, our prescribers cover this during the clinical review process.
A question our prescribers hear most weeks is whether the abdomen or thigh is "better". The honest answer is that there is no clinical winner between the three licensed sites; the best one is whichever you can reach comfortably and remember to rotate. Consistency in the day of the week matters far more than which site you pick.
Remove the outer cap, attach a new needle (if your pen uses separate needles), and follow the pen's priming step if it is the first use of that pen, the instructions in your leaflet will walk you through this in under a minute. Press the pen firmly against the skin, press the button until you hear a click, then hold it in place for a full 10 seconds before pulling it away. That pause gives the full dose time to be delivered.
After the injection, recap the needle carefully and place it directly into your sharps container, never into a household bin. A small red mark or mild itch at the site is normal and usually fades within a few hours. If you notice swelling, warmth or pain that persists beyond a day or two at that site, let your prescribing team know.
For a broader look at how Mounjaro fits into a weekly routine, including timing tips around travel or shift work, that resource covers practical questions that come up once treatment is established. You can also read more about tirzepatide as a treatment to understand the clinical context behind the dose schedule.
Tirzepatide treatment is not static. The 2.5 mg starting dose is a tolerability step; its job is to let your body adjust rather than to produce significant weight loss. Your prescriber will typically review your response every four weeks and may increase the dose through the available strengths: 5, 7.5, 10, 12.5, and up to 15 mg. That progression happens at the pace your system tolerates, not on a fixed calendar.
One practical question comes up often: can you take tirzepatide if your usual day falls on a holiday, or you simply forget? The short answer is that the injection should happen once every seven days, but if you miss your planned day you have a short window to catch up, the specific guidance lives in your Patient Information Leaflet, and your prescriber is the right person to advise if you are unsure. The NICE appraisal of tirzepatide, TA1026, notes that if less than 5% weight loss is achieved after six months at the highest tolerated dose, continuation should be reviewed.
Because Eli Lilly raised the UK list price for Mounjaro in September 2025, the cost of treatment is worth factoring into long-term planning. Our coverage of the Mounjaro price increase sets out what changed and what it means for patients sourcing treatment privately. Understanding how often tirzepatide is taken across the full dose ladder also helps with planning ahead. And if you have come across unfamiliar terminology, a quick note on how to pronounce tirzepatide is available for anyone who wants it before their first appointment.
If clinical assessment confirms tirzepatide is appropriate for you, treatment at our GPhC-registered pharmacy includes the prescription, clinical review, and free next-working-day delivery, with prescribers available seven days a week for aftercare questions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.